Spots Global Cancer Trial Database for srs
Every month we try and update this database with for srs cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SRS Sequential Sindilimab in Brain Metastasis of NSLSC | NCT04180501 | NSCLC Stage IV Brain Metastase... SRS Sintilimab | SRS sequential ... | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital | |
| Camrelizumab Combined With Local Treatment in NSCLC Patients With BM | NCT04291092 | NSCLC Stage IV Brain Metastase... Immunotherapy | Immunotherapy WBRT Chemotherapy | 18 Years - | Zhejiang Cancer Hospital | |
| Hypofractionated Brain Radiationcavity | NCT03561896 | Brain Metastase... Cancer Brain | IGRT SRS | 18 Years - | Oncology Institute of Southern Switzerland | |
| REMASTer: REcurrent Brain Metastases After SRS Trial | NCT05124912 | Brain Metastase... Radiation Necro... Recurrent Tumor Recurrent Metas... | Radiation Thera... Steroid Therapy Laser Interstit... | 18 Years - | Monteris Medical | |
| Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
| Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | NCT03956706 | Glioblastoma Astrocytoma, Gr... Astrocytoma, Gr... Malignant Gliom... | Stereotactic Ra... | 18 Years - | Northwell Health | |
| Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets | NCT01721603 | BRAFV600E Melan... | Dabrafenib Gamma Knife Rad... Trametinib | 18 Years - | University of California, San Francisco | |
| Study of Temozolomide to Treat Newly Diagnosed Brain Metastases | NCT00717275 | Brain Metastase... | Temozolomide | 18 Years - | University of Florida | |
| Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
| Camrelizumab Combined With Local Treatment in NSCLC Patients With BM | NCT04291092 | NSCLC Stage IV Brain Metastase... Immunotherapy | Immunotherapy WBRT Chemotherapy | 18 Years - | Zhejiang Cancer Hospital | |
| Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | NCT03956706 | Glioblastoma Astrocytoma, Gr... Astrocytoma, Gr... Malignant Gliom... | Stereotactic Ra... | 18 Years - | Northwell Health | |
| Radiotherapy for Solid Tumor Spine Metastases | NCT01752036 | Solid Tumor Spi... | Post-operative,... | 12 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma | NCT04225039 | Glioblastoma | INCMGA00012 INCAGN01876 SRS Brain surgery | 18 Years - | University of Pennsylvania | |
| Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC | NCT03769103 | Lung Cancer Non... Brain Metastase... | Osimertinib Stereotactic ra... | 18 Years - | British Columbia Cancer Agency | |
| High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases | NCT02726568 | Non-small Cell ... Brain Metastase... | Icotinib SRS | 18 Years - 75 Years | Betta Pharmaceuticals Co., Ltd. | |
| Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets | NCT01721603 | BRAFV600E Melan... | Dabrafenib Gamma Knife Rad... Trametinib | 18 Years - | University of California, San Francisco | |
| Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial | NCT03075072 | Brain Metastase... | Whole brain rad... Stereotactic ra... | 18 Years - 80 Years | Dana-Farber Cancer Institute | |
| A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases | NCT05033691 | NSCLC EGFR Gene Mutat... EGF-R Positive ... Non-small Cell ... Brain Metastase... | Stereotactic su... | 18 Years - 120 Years | Hadassah Medical Organization | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital | |
| Radiotherapy for Solid Tumor Spine Metastases | NCT01752036 | Solid Tumor Spi... | Post-operative,... | 12 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases? | NCT05378633 | Brain Metastase... Nsclc | SRS Whole Brain Rad... | 18 Years - | University Hospital Heidelberg | |
| Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | NCT00470847 | Breast Cancer Brain Metastase... | Lapatinib Whole Brain Rad... Herceptin | 18 Years - | Dana-Farber Cancer Institute | |
| SRS Sequential Sindilimab in Brain Metastasis of NSLSC | NCT04180501 | NSCLC Stage IV Brain Metastase... SRS Sintilimab | SRS sequential ... | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma | NCT04225039 | Glioblastoma | INCMGA00012 INCAGN01876 SRS Brain surgery | 18 Years - | University of Pennsylvania | |
| SRS Sequential Sindilimab in Brain Metastasis of NSLSC | NCT04180501 | NSCLC Stage IV Brain Metastase... SRS Sintilimab | SRS sequential ... | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| Hypofractionated Brain Radiationcavity | NCT03561896 | Brain Metastase... Cancer Brain | IGRT SRS | 18 Years - | Oncology Institute of Southern Switzerland | |
| Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma | NCT04225039 | Glioblastoma | INCMGA00012 INCAGN01876 SRS Brain surgery | 18 Years - | University of Pennsylvania | |
| TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine | NCT04671459 | Glioblastoma Mu... Recurrent Gliob... | TTFields and SR... | 18 Years - | Prof. Franciszek Lukaszczyk Memorial Oncology Center | |
| Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases | NCT03297788 | SCLC Brain Metastase... | SRS WBRT | 18 Years - | University Hospital Heidelberg | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
